Triethylamine → (2R,4S)-5-Biphenyl-4-yl-2-methyl-4-(1H-tetrazol-5-ylcarbamoyl)-pentanoic acid ethyl ester
반응식
Cl.[CH2:2]([O:4][C:5](=[O:24])[C@H:6]([CH3:23])[CH2:7][C@H:8](N)[CH2:9][C:10]1[CH:15]=[CH:14][C:13]([C:16]2[CH:21]=[CH:20][CH:19]=[CH:18][CH:17]=2)=[CH:12][CH:11]=1)[CH3:3].Cl.C(O[C:29](=[O:49])[C@@H](C)CC(N)CC1C=CC(C2C=CC=C(Cl)C=2)=CC=1)C.CC[N:52](CC)CC.CN(C(O[N:65]1[N:73]=[N:72]C2C=CC=[N:71][C:66]1=2)=[N+](C)C)C.F[P-](F)(F)(F)(F)F>[Pd].CN(C=O)C.C(Cl)Cl>[CH2:2]([O:4][C:5](=[O:24])[C@H:6]([CH3:23])[CH2:7][C@H:8]([C:29](=[O:49])[NH:71][C:66]1[NH:52][N:72]=[N:73][N:65]=1)[CH2:9][C:10]1[CH:15]=[CH:14][C:13]([C:16]2[CH:21]=[CH:20][CH:19]=[CH:18][CH:17]=2)=[CH:12][CH:11]=1)[CH3:3]참가 물질
8
반응물 4
생성물 1
시약·촉매·용매 3
실험 절차
Prepared using similar procedure described in Example 52-1 with appropriate intermediates and conditions. Intermediate 1 and benzyl-H-tetrazole-5-carbonyl chloride (prepared according to J. Med. Chem. 1986, 29, 538-549) are used instead of intermediates 31 and 32. For coupling reaction, Et3N and DCM are used instead of HATU and DMF. For deprotection, hydrogeneation with Pd on carbon is used instead of TFA.
후처리
- customPrepared
출처 및 근거
- ORD 기록
- ord-91a384849d6342a18903e1f4ff5a1853
- 출처 데이터셋
- uspto-grants-2015_04
- 특허 번호
- US09006249B2
반응 노트
불러오는 중…